News

Invest Northwest CEO And Investor Forum, 3/17-18, Seattle, WA – LigoCyte Pharmaceuticals, Inc.

January 9, 2009 /

MATR Sponsor (view all)

Bear Paw Development Corporation is a private non-profit organization created for the purpose of administering programs to help improve regional economic conditions in Hill, Blaine, Liberty, Chouteau and Phillips Counties and the Fort Belknap and Rocky Boy's Indian Reservations.

Invest Northwest 2009 http://www.investnorthwest.org/presenters.html is the region’s premier life sciences investment conference, where public and private life science companies tell their stories to institutional investors, analysts, investment bankers, fund managers, venture capitalists, angel investors, and prospective corporate partners.

http://www.investnorthwest.org/presenters.html

***

Ligocyte http://www.ligocyte.com/

LigoCyte Pharmaceuticals, Inc. is a private, biopharmaceutical company focused on the development of innovative vaccine products
based on the company’s proprietary virus-like particle platform technology. LigoCyte’s lead candidate recently completed a Phase
I clinical trial for the prevention of norovirus, a ubiquitous and prostrating illness characterized by a fever, vomiting and diarrhea.
LigoCyte also has a novel influenza vaccine in preclinical development that has, notably, demonstrated protection across multiple
influenza subtypes with a single VLP antigen. Incorporated in 1998, LigoCyte has 45 employees and is located in Bozeman, Montana.